jameshebrew  created a new article
2 yrs

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies | #car-t # car t cell therapy # car-t therapy # car t cell therapy market # car t cell therapy companies

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies

Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market
Like